Lv1
60 积分 2025-08-22 加入
Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity
7个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
8个月前
已完结
Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma
8个月前
已完结
A paradigm of cancer immunotherapy based on 2-[18F]FDG and anti-PD-L1 mAb combination to enhance the anti-tumor effect
9个月前
已完结
Engineering sonogenetic EchoBack-CAR T cells
9个月前
已完结
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma
9个月前
已完结
ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis
9个月前
已完结
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
10个月前
已完结
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
10个月前
已完结
From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
11个月前
已完结
皖公网安备34019202002308
